5-hydroxytryptophan has been researched along with Blood Pressure, High in 20 studies
5-Hydroxytryptophan: The immediate precursor in the biosynthesis of SEROTONIN from tryptophan. It is used as an antiepileptic and antidepressant.
5-hydroxytryptophan : A tryptophan derivative that is tryptophan substituted by a hydroxy group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| " These results suggest that chronic administration of L-5-HTP provides significant protection against the development of DOCA-induced hypertension, polydipsia, polyuria, and cardiac hypertrophy in rats." | 5.27 | Chronic treatment with L-5-hydroxytryptophan prevents the development of DOCA-salt-induced hypertension in rats. ( Fregly, MJ; Lockley, OE; Sumners, C, 1987) |
| " These results suggest that chronic administration of L-5-HTP was effective in reducing the elevated blood pressure in the DS model." | 1.28 | Reduction in the elevated blood pressure of Dahl salt-sensitive rats treated chronically with L-5-hydroxytryptophan. ( Baron, A; Fregly, MJ; Riesselmann, A, 1991) |
| "Cardiac hypertrophy was associated with Dahl salt-induced hypertension." | 1.28 | Reduction in the elevated blood pressure of Dahl salt-sensitive rats treated chronically with L-5-hydroxytryptophan. ( Baron, A; Fregly, MJ; Riesselmann, A, 1991) |
| " These results suggest that chronic administration of L-5-HTP provides significant protection against the development of DOCA-induced hypertension, polydipsia, polyuria, and cardiac hypertrophy in rats." | 1.27 | Chronic treatment with L-5-hydroxytryptophan prevents the development of DOCA-salt-induced hypertension in rats. ( Fregly, MJ; Lockley, OE; Sumners, C, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (85.00) | 18.7374 |
| 1990's | 1 (5.00) | 18.2507 |
| 2000's | 1 (5.00) | 29.6817 |
| 2010's | 1 (5.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borroni, E | 1 |
| Bohrmann, B | 1 |
| Grueninger, F | 1 |
| Prinssen, E | 1 |
| Nave, S | 1 |
| Loetscher, H | 1 |
| Chinta, SJ | 1 |
| Rajagopalan, S | 1 |
| Rane, A | 1 |
| Siddiqui, A | 1 |
| Ellenbroek, B | 1 |
| Messer, J | 1 |
| Pähler, A | 1 |
| Andersen, JK | 1 |
| Wyler, R | 1 |
| Cesura, AM | 1 |
| Maron, E | 1 |
| Tõru, I | 1 |
| Vasar, V | 1 |
| Shlik, J | 1 |
| Yao, T | 1 |
| Andersson, S | 1 |
| Thoren, P | 1 |
| Nagatsu, T | 1 |
| Fuller, RW | 1 |
| Holland, DR | 1 |
| Yen, TT | 1 |
| Bemis, KG | 1 |
| Stamm, NB | 1 |
| Lindqvist, M | 1 |
| Kehr, W | 1 |
| Carlsson, A | 1 |
| Baron, A | 1 |
| Riesselmann, A | 1 |
| Fregly, MJ | 2 |
| Koulu, M | 1 |
| Saavedra, JM | 1 |
| Bjelogrlic, N | 1 |
| Niwa, M | 1 |
| Agren, H | 1 |
| Linnoila, M | 1 |
| Itskovitz, HD | 2 |
| Werber, JL | 1 |
| Sheridan, AM | 1 |
| Brewer, TF | 2 |
| Stier, CT | 2 |
| Lockley, OE | 1 |
| Sumners, C | 1 |
| Tsai, CF | 1 |
| Lin, MT | 1 |
| Dick, LB | 1 |
| Wynn, N | 1 |
| Denoroy, L | 1 |
| Tappaz, ML | 1 |
| Fety, R | 1 |
| Vincent, M | 1 |
| Renaud, B | 1 |
| Sassard, J | 1 |
| O'Steen, WK | 1 |
| Hall, CE | 1 |
| Hall, OS | 1 |
| Nath, K | 1 |
| Agarwal, SN | 1 |
| Mittal, HS | 1 |
| Singh, KN | 1 |
| Saxena, S | 1 |
| Pant, H | 1 |
| Grollman, A | 1 |
| Krishnamurty, VS | 1 |
| Wardle, EN | 1 |
| Laborit, H | 1 |
| Ozaki, M | 1 |
| Tabei, R | 1 |
| Spector, S | 1 |
| Louis, WJ | 1 |
| Sjoerdsma, A | 1 |
1 trial available for 5-hydroxytryptophan and Blood Pressure, High
| Article | Year |
|---|---|
The effect of 5-hydroxytryptophan on cholecystokinin-4-induced panic attacks in healthy volunteers.
Topics: 5-Hydroxytryptophan; Administration, Oral; Adolescent; Adult; Capsules; Cognition Disorders; Double- | 2004 |
19 other studies available for 5-hydroxytryptophan and Blood Pressure, High
| Article | Year |
|---|---|
Sembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer's Disease.
Topics: 5-Hydroxytryptophan; Acetamides; Alzheimer Disease; Animals; Astrocytes; Gliosis; Humans; Hypertensi | 2017 |
Long-lasting cardiovascular depressor response following sciatic stimulation in spontaneously hypertensive rats. Evidence for the involvement of central endorphin and serotonin systems.
Topics: 5-Hydroxytryptophan; Animals; Blood Pressure; Brompheniramine; Dexamethasone; Electric Stimulation; | 1982 |
[Tyrosine hydroxylase (author's transl)].
Topics: 5-Hydroxytryptophan; Adrenal Glands; Brain; Catecholamines; Chemical Phenomena; Chemistry; Coenzymes | 1976 |
Antihypertensive effects of fluoxetine and L-5-hydroxytryptophan in rats.
Topics: 5-Hydroxytryptophan; Animals; Antihypertensive Agents; Blood Pressure; Desoxycorticosterone; Drug In | 1979 |
Attempts to measure endogenous levels of dopa and 5-hydroxytryptophan in rat brain.
Topics: 5-Hydroxytryptophan; Animals; Apomorphine; Brain Chemistry; Chlorpromazine; Dihydroxyphenylalanine; | 1975 |
Reduction in the elevated blood pressure of Dahl salt-sensitive rats treated chronically with L-5-hydroxytryptophan.
Topics: 5-Hydroxytryptophan; Animals; Blood Pressure; Body Weight; Cardiomegaly; Desoxycorticosterone; Femal | 1991 |
Serotonin turnover in discrete hypothalamic nuclei and mesencephalic raphe nuclei of young and adult spontaneously hypertensive rats.
Topics: 5-Hydroxytryptophan; Aging; Animals; Hydroxyindoleacetic Acid; Hypertension; Hypothalamus; Kinetics; | 1986 |
5-Hydroxytryptophan and carbidopa in spontaneously hypertensive rats.
Topics: 5-Hydroxytryptophan; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Blood Pressure; Brain; C | 1989 |
Chronic treatment with L-5-hydroxytryptophan prevents the development of DOCA-salt-induced hypertension in rats.
Topics: 5-Hydroxytryptophan; Administration, Cutaneous; Angiotensin II; Animals; Cardiomegaly; Catecholamine | 1987 |
Pain sensitivity, thermal capability, and brain monoamine turnover in hypertensive rats.
Topics: 5-Hydroxytryptophan; Amines; Animals; Body Temperature Regulation; Brain; Dihydroxyphenylalanine; Hy | 1987 |
Formation of biogenic amines by isolated kidneys of spontaneously hypertensive rats.
Topics: 5-Hydroxytryptophan; Animals; Dopamine; Hypertension; Kidney; Levodopa; Norepinephrine; Perfusion; R | 1986 |
Rate of tryptophan hydroxylation in vivo in brain nuclei of genetically hypertensive rats of the Lyon strain.
Topics: 5-Hydroxytryptophan; Aging; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Brain; Hydrazines | 1985 |
Hormone influenced hypertension in the male rat. Effect of hydrochlorothiazide.
Topics: 5-Hydroxytryptophan; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Cardiomegaly; Ce | 1969 |
Urinary 5-hydroxyindoleacetic acid in cases of hypertension before and after therapy with guanethidine and methyldopa.
Topics: 5-Hydroxytryptophan; Guanethidine; Humans; Hydroxyindoleacetic Acid; Hypertension; Methyldopa; Serot | 1972 |
Contractile response of the aorta of the normotensive and acute and chronic hypertensive rat.
Topics: 5-Hydroxytryptophan; Acute Disease; Animals; Aorta; Blood Pressure; Calcium; Chronic Disease; Dose-R | 1973 |
The relevance of intravascular coagulation to pre-eclampsia.
Topics: 5-Hydroxytryptophan; Abruptio Placentae; Animals; Blood Coagulation Factors; Desoxycorticosterone; D | 1973 |
[Advantages of restoring the granular catecholamine stock and of SH groups in the treatment of so-called "irreversible" hemorrhagic shock].
Topics: 5-Hydroxytryptophan; Animals; Catecholamines; Cell Membrane Permeability; Chlorpromazine; Dogs; Dopa | 1969 |
Metabolism of monoamines in spontaneously hypertensive rat.
Topics: 5-Hydroxytryptophan; Animals; Blood Pressure; Brain; Hypertension; Kidney; Liver; Male; Monoamine Ox | 1966 |
Antihypertensive and noradrenaline-depleting effects of alpha-methyl-5-hydroxytryptophan in the rat.
Topics: 5-Hydroxytryptophan; Animals; Blood Pressure; Brain Stem; Female; Hydrazines; Hypertension; Methylty | 1969 |